David Lewin to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications David Lewin has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.158
-
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party. Lung Cancer. 2012 Sep; 77(3):605-10.
Score: 0.081
-
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
Score: 0.078